Additional Funding Awarded for Regenerative Cartilage Therapy Development
Mogrify has announced that it has secured $1.1M of additional funding from SBRI Healthcare to assess its regenerative cartilage therapy.READ MORE
Horizon Licenses Use of GS Knockout CHO K1 Cell Line to NGM Bio
Horizon has announced that it will license its gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line to NGM Biopharmaceuticals.READ MORE
International Freezer Challenge 2020: Optimizing Your Cold Storage Practices?
The International Institute for Sustainable Laboratories (I2SL) and MyGreenLab have partnered again to reward the best concept to improve cold storage regarding sustainability: The Freezer Challenge 2020.READ MORE
Advanced BioMatrix Acquires HyStem® from Lineage Cell Therapeutics
Advanced BioMatrix has acquired the HyStem® line of products, used for making customizable 3D hydrogels, from Lineage Cell Therapeutics.READ MORE
BioMed X Starts New Research Program in Autoimmune Diseases with Merck
BioMed X has announced the start of a new joint research group in collaboration with Merck, which will focus on the role of the intestinal epithelial barrier in the development and exacerbation of autoimmune diseases.READ MORE
Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture
Avacta and Daewoong Pharmaceutical have announced a collaboration to develop the next generation of cell and gene therapies incorporating Affimer proteins to enhance the immune-modulatory effects.